Skip to main content

Table 2 Clinical data

From: Psychological symptoms during and after Austrian first lockdown in individuals with bipolar disorder? A follow-up control-group investigation

  BD (n = 20) Controls (n = 20) Statistics
Mood stabilizers
 Lithium 30%  
 Atypical antipsychotics 35%  
 Anticonvulsants 10%  
 Others 25%  
Somatic comorbidities
 Cardiovascular disease 5 0 χ2(1) = 5.71, p = 0.017a
 Diabetes mellitus 3 0 χ2(1) = 3.24, p = 0.231a
 Obstructive pulmonary disease 2 0 χ2(1) = 2.11, p = 0.487a
 Hypertension 6 2 χ2(1) = 2.50, p = 0.114
Symptom self-ratings
 BDI-2 (M, SD), April 15.45 (10.74) 3.10 (2.53) t(38) = 5.00, p < 0.001
 BDI-2 (M, SD), May 12.20 (11.69) 2.40 (2.21) t(38) = 3.69, p < 0.01
 ASRM (M, SD), April 0.95 (2.28) 0.55 (1.19) t(38) = 0.70, p = 0.491
 ASRM (M, SD), May 1.5 (2.19) 0.25 (0.55) t(38) = 2.48, p = 0.022
  1. BD  bipolar disorder, BDI-2  beck depression inventory-2, ASRM Altman self-rating mania scale, M  mean, SD  standard deviation
  2. aFisher’s exact test